Heart rhythm problems, also known as arrhythmias, can be frightening and life-threatening. But new research from The Ohio State University offers fresh hope. Scientists there have made a major breakthrough in understanding a key protein that helps control our heartbeat. This discovery could lead to better treatments in the future.
The research was led by assistant professor Przemysław Radwanski. His team studied a small but powerful protein called calmodulin. This protein is found in many parts of the body, including the heart.
In the heart, it plays a vital role by helping control how calcium and sodium—two charged particles—move in and out of heart cells. This movement is what keeps our heart beating regularly and steadily.
When the system works as it should, calmodulin helps maintain a normal rhythm in our heart’s electrical signals. These signals can be seen in an electrocardiogram, or ECG, which doctors use to check how the heart is functioning.
However, some people are born with a mutation—a small change—in their calmodulin protein. This rare condition leads to what scientists now call “calmodulinopathies,” which are serious and often deadly heart rhythm disorders. Because these mutations are not well understood, it has been hard for doctors to treat them effectively.
Radwanski’s team focused on one specific mutation of calmodulin called D96V-CaM. What they found was eye-opening. This mutated form causes too much sodium to enter the heart cells. That, in turn, leads to the heart releasing calcium in a strange and irregular way. This chaotic process can trigger dangerous heart rhythm problems.
By studying this mutation in detail, the team uncovered something even more important: it affects a particular sodium channel called NaV1.6. This channel is less common than another one called NaV1.5, which is normally found in heart muscle. But in the case of this mutation, NaV1.6 plays a bigger role than previously thought.
This new understanding opens the door for future treatments that target the NaV1.6 channel specifically. If researchers can find drugs that affect only this channel, they might be able to help people with calmodulin-related arrhythmias—and possibly other types of rhythm problems as well.
Professor Radwanski said this study is a big step forward. “Our goal is to find treatments that stop dangerous heart rhythms not only from calmodulin mutations but also from other issues with sodium channels,” he explained.
The study was published in the Journal of Clinical Investigation. It gives scientists a clearer picture of what goes wrong in certain heart conditions and how they might be able to fix it in the future.
For people living with or at risk of heart rhythm disorders, this research brings real hope. It shows that science is moving closer to understanding and treating these scary and deadly problems, possibly offering a safer and more targeted approach than what’s available today.
If you care about heart health, please read studies that vitamin K helps cut heart disease risk by a third, and a year of exercise reversed worrisome heart failure.
For more health information, please see recent studies about supplements that could help prevent heart disease, stroke, and results showing this food ingredient may strongly increase heart disease death risk.
Copyright © 2025 Knowridge Science Report. All rights reserved.
